Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Effect of Tocilizumab on “Ventilator Free Days” Composite Outcome in SARS-CoV-2 Patients: A Retrospective Competing Risk Analysis
Saved in:
| Published in: | Romanian Journal of Anaesthesia and Intensive Care |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2023
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1868575983956656128 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | Romanian Journal of Anaesthesia and Intensive Care |
| description | |
| discipline_display | Anaesthesiology |
| discipline_facet | Anaesthesiology |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:84391 |
| institution | FRELIP |
| journal_source_facet | Romanian Journal of Anaesthesia and Intensive Care |
| last_indexed | 2026-06-21T03:35:24.146Z |
| publishDate | 2023 |
| publishDateSort | 2023 |
| record_format | rss_article |
| spellingShingle | Effect of Tocilizumab on “Ventilator Free Days” Composite Outcome in SARS-CoV-2 Patients: A Retrospective Competing Risk Analysis Anaesthesiology General Anaesthesiology |
| sub_discipline_display | General |
| sub_discipline_facet | General |
| subject_display | Anaesthesiology General Anaesthesiology |
| subject_facet | Anaesthesiology General Anaesthesiology |
| title | Effect of Tocilizumab on “Ventilator Free Days” Composite Outcome in SARS-CoV-2 Patients: A Retrospective Competing Risk Analysis |
| title_alt | Efecto de tocilizumab en el resultado compuesto de "días libres de ventilador" en pacientes con SARS-CoV-2: un análisis retrospectivo de riesgos competitivos Effet du tocilizumab sur le critère composite « jours sans ventilateur » chez les patients atteints de SARS-CoV-2 : une analyse rétrospective des risques concurrents Efeito do tocilizumabe no desfecho composto de "dias livres de ventilador" em pacientes com SARS-CoV-2: Uma análise retrospectiva de risco competitivo |
| title_auth | Effect of Tocilizumab on “Ventilator Free Days” Composite Outcome in SARS-CoV-2 Patients: A Retrospective Competing Risk Analysis |
| title_es_txt | Efecto de tocilizumab en el resultado compuesto de "días libres de ventilador" en pacientes con SARS-CoV-2: un análisis retrospectivo de riesgos competitivos |
| title_fr_txt | Effet du tocilizumab sur le critère composite « jours sans ventilateur » chez les patients atteints de SARS-CoV-2 : une analyse rétrospective des risques concurrents |
| title_full | Effect of Tocilizumab on “Ventilator Free Days” Composite Outcome in SARS-CoV-2 Patients: A Retrospective Competing Risk Analysis |
| title_fullStr | Effect of Tocilizumab on “Ventilator Free Days” Composite Outcome in SARS-CoV-2 Patients: A Retrospective Competing Risk Analysis |
| title_full_unstemmed | Effect of Tocilizumab on “Ventilator Free Days” Composite Outcome in SARS-CoV-2 Patients: A Retrospective Competing Risk Analysis |
| title_pt_txt | Efeito do tocilizumabe no desfecho composto de "dias livres de ventilador" em pacientes com SARS-CoV-2: Uma análise retrospectiva de risco competitivo |
| title_short | Effect of Tocilizumab on “Ventilator Free Days” Composite Outcome in SARS-CoV-2 Patients: A Retrospective Competing Risk Analysis |
| title_sort | effect of tocilizumab on “ventilator free days” composite outcome in sars-cov-2 patients: a retrospective competing risk analysis |
| topic | Anaesthesiology General Anaesthesiology |
| url | https://sciendo.com/article/10.2478/rjaic-2022-0001 |